Treatment of dystonia in Parkinson's disease

被引：0
作者：
Tsui, JKC [1 ]
机构：
[1] Univ British Columbia, Ctr Neurodegenerat Disorders, Vancouver, BC, Canada
来源：
PARKINSON'S DISEASE | 2003年 / 91卷
关键词：
D O I：
暂无
中图分类号：
Q3 [遗传学];
学科分类号：
071007 ; 090102 ;
摘要：
引用
收藏
页码：361 / 364
页数：4
相关论文
共 21 条
  • [1] Early morning dystonia in Parkinson's disease
    Currie, LJ
    Harrison, MB
    Trugman, JM
    Bennett, JP
    Wooten, GF
    [J]. NEUROLOGY, 1998, 51 (01) : 283 - 285
  • [2] Djaldetti R, 1999, MOVEMENT DISORD, V14, P443, DOI 10.1002/1531-8257(199905)14:3<443::AID-MDS1009>3.0.CO
  • [3] 2-G
  • [4] Methods of managing levodopa-induced dyskinesias
    Giron, LT
    Koller, WC
    [J]. DRUG SAFETY, 1996, 14 (06) : 365 - 374
  • [5] Katchen M, 1986, Mov Disord, V1, P151, DOI 10.1002/mds.870010210
  • [6] FORMS OF DYSTONIA IN PATIENTS WITH PARKINSONS-DISEASE
    KIDRON, D
    MELAMED, E
    [J]. NEUROLOGY, 1987, 37 (06) : 1009 - 1011
  • [7] ADDUCTOR LARYNGEAL BREATHING DYSTONIA IN A PATIENT WITH LUBAG (X-LINKED DYSTONIA-PARKINSONISM SYNDROME)
    LEW, MF
    SHINDO, M
    MOSKOWITZ, CB
    WILHELMSEN, KC
    FAHN, S
    WATERS, CH
    [J]. MOVEMENT DISORDERS, 1994, 9 (03) : 318 - 320
  • [8] DYSTONIA IN UNTREATED PARKINSONISM
    LEWITT, PA
    BURNS, RS
    NEWMAN, RP
    [J]. CLINICAL NEUROPHARMACOLOGY, 1986, 9 (03) : 293 - 297
  • [9] Treatment of dystonia occurring in parkinsonian syndromes by botulinum toxin
    Limousin, P
    Memin, B
    Pollak, P
    [J]. EUROPEAN NEUROLOGY, 1997, 37 (01) : 66 - 67
  • [10] LEVODOPA-ASSOCIATED HEMIFACIAL DYSTONIA
    MARK, MH
    SAGE, JI
    [J]. MOVEMENT DISORDERS, 1991, 6 (04) : 383 - 383
123